ロード中...
A Comparison of Pharmaceutical Budget Impact Analysis (BIA) Recommendations Amongst the Canadian Patented Medicine Prices Review Board (PMPRB), Public and Private Payers
The Canadian budget impact analysis (BIA) guidelines were published by the Patented Medicine Prices Review Board (PMPRB) in 2007. Some Canadian federal, provincial and territorial (F/P/T) drug plans have updated their BIA guidelines since then. The aim of the present review was to provide a comprehe...
保存先:
| 出版年: | Pharmacoecon Open |
|---|---|
| 主要な著者: | , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Springer International Publishing
2019
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6861390/ https://ncbi.nlm.nih.gov/pubmed/31041614 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s41669-019-0139-y |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|